Atena Abed | Cancer | Innovative Research Award

Innovative Research Award

Atena Abed
Affiliation Shahrekord University of Medical Science
Country Iran
Scopus ID 57218291844
Documents 8
Citations 238
h-index 4
Subject Area Cancer research
Award Innovative Research Award
Event International Research Chemistry Awards
ORCID 0000-0001-6408-5953

Atena Abed is a researcher affiliated with Shahrekord University of Medical Science in Iran whose identified subject area is cancer research. Her academic profile is associated with the Innovative Research Award presented under the International Research Chemistry Awards. The supplied bibliometric information records eight documents, citations, and an h-index. These indicators provide a quantitative overview of the research output and citation activity reported for the profile. [1]

Abstract

Atena Abed is a researcher affiliated with Shahrekord University of Medical Science, Iran, specializing in cancer research. Her profile is associated with the Innovative Research Award of the International Research Chemistry Awards. Her research profile and scholarly impact can be further evaluated through verified publications and bibliometric records.[1]

Keywords

Atena Abed; cancer research; oncology research; biomedical science; scientific innovation; research publications; citation analysis; h-index; scholarly impact; Innovative Research Award; International Research Chemistry Awards; Iran.[2]

Introduction

Cancer research is an interdisciplinary field that brings together molecular biology, biochemistry, genetics, pharmacology, pathology, clinical medicine, and data-driven approaches to improve the understanding and management of cancer. Research in this area can contribute to identifying disease-associated mechanisms, evaluating candidate therapeutic compounds, improving diagnostic approaches, and exploring strategies for prevention and patient care.[1]

Research Profile

Atena Abed is listed as affiliated with Shahrekord University of Medical Science, Iran. The supplied Scopus Author ID and the ORCID identifier . These identifiers provide routes to researcher records and can assist with distinguishing scholarly profiles when names or affiliations overlap. The completeness and current status of individual profile records should be confirmed directly through the relevant services.[2]

Research Contributions

Atena Abed, cancer research is the subject area specified in the supplied award profile. A detailed account of individual contributions would require examination of verified publications and their abstracts, methods, results, and conclusions. Without those records, it would be inappropriate to attribute particular discoveries, clinical applications, therapeutic advances, or laboratory techniques to the researcher.[3]

Publications

Publications are a principal means through which researchers communicate research questions, methods, results, and interpretations to the scientific community. Assessing an individual publication record requires consideration of the relevance and quality of the work, the research design, the contribution of each author, and the extent to which the findings have been validated or developed by subsequent studies.[4]

Research Impact

The supplied bibliometric indicators for Atena Abed comprise eight documents, citations, and an h-index. These measures describe different aspects of scholarly activity and should be interpreted together with the subject area, publication history, career stage, and nature of the research. Citation counts alone do not establish scientific quality, clinical relevance, methodological reliability, or societal benefit. [2]

Award Suitability

Innovation in research may involve the development of new methods, the generation of original scientific insights, the application of established techniques to new problems, or contributions that enable further investigation. A fair assessment should consider documented achievements and the quality of the evidence supporting the nomination.[3]

Conclusion

Atena Abed is presented in this academic profile as a researcher affiliated with Shahrekord University of Medical Science in Iran, with cancer research identified as the subject area and the Innovative Research Award listed under the International Research Chemistry Awards. The supplied record reports eight documents, citations.[4]

References

    1. Elsevier. (n.d.). Scopus author details: Atena Abed, Author ID 57218291844. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=57218291844
    2. ORCID. (n.d.). ORCID record: 0000-0001-6408-5953.
      https://orcid.org/0000-0001-6408-5953
    3. International Research Chemistry Awards. (n.d.).
      https://researchchemistry.org/
    4. Dalilgo, H., Soleimani, Z., Esalatmanesh, K., Gilasi, H., Amini Mahabadi, J., & Abed, A. (2026). Investigation of the correlation between serum levels of interleukin-6 and clinical and paraclinical findings in COVID-19 patients. Current Therapeutic Research, Clinical and Experimental.
      https://doi.org/10.1016/j.curtheres.2026.100847

Prof. Wei Chong | Oncology | Best Researcher Award

Prof. Wei Chong | Oncology | Best Researcher Award

Professor at Shandong Provincial Hospital China

Professional Profiles

Scopus

Orcid

šŸŽ“ Educational Background

Dr. Chong Wei has pursued a distinguished academic journey in the field of oncology and gastrointestinal research. She earned her Bachelor’s degree in Biotechnology from Shandong Second Medical University (2011-2015). She then obtained a Doctoral degree in Oncology from Tianjin Medical University Cancer Hospital (2015-2020), where she focused on cancer research and treatment strategies. Further advancing her expertise, she completed her Postdoctoral research in Surgery at Shandong Provincial Hospital (2021-2023), specializing in multi-omics molecular typing and precision treatment of digestive tract tumors.

šŸ„ Professional Experience

Dr. Chong Wei has made significant contributions to medical research and education. She began her career as a Research Assistant in the Department of Gastrointestinal Surgery at Shandong First Medical University Affiliated Provincial Hospital (2020-2022). She later became an Associate Professor at the Medical Science and Technology Innovation Center of Shandong First Medical University (2020-2025). Currently, she serves as a Postdoctoral Supervisor (since 2021) and Master’s Advisor (since 2022) in the Department of Gastrointestinal Surgery. Additionally, she holds the position of Deputy Director at the Laboratory of Basic and Clinical Oncology of Digestive Tract (since 2022).

šŸ† Awards in Scientific and Technological Achievements

Dr. Chong Wei’s groundbreaking research has earned her multiple prestigious awards:

Shandong Province Science and Technology Progress Award (Second Prize, 2021) – For establishing a diagnostic and treatment system for colorectal cancer based on molecular markers and tumor microenvironment characteristics.

Third Prize of Youth Science and Technology Award (2023) – Recognized by the Shandong Medical Association for her work on tumor markers and precision diagnosis of digestive tract tumors.

First Prize of Science and Technology Award (2023) – Awarded by the Shandong Medical Engineering Society for her development of an automatic monitoring system for digestive tract tumor markers.

šŸ… Honors & Recognitions

Dr. Chong Wei has received several prestigious accolades for her contributions to cancer research:

Excellence Award (2022) – Presented at the 17th National Gastric Cancer Academic Conference as part of the Gastric Cancer Future Scientist Award.

Third Prize (2024) – Received at the 18th National Gastric Cancer Academic Conference for her continued research on gastric cancer advancements.

Outstanding Poster Award (2022) – Honored by the Medical Science and Technology Innovation Center for presenting innovative research findings.

šŸ”¬ Research Focus & Impact

Dr. Chong Wei’s research centers on multi-omics molecular typing and precision medicine for digestive tract tumors. Her work aims to revolutionize cancer diagnosis and treatment through advanced molecular analysis and targeted therapeutic approaches. She has played a key role in developing tumor biomarker screening techniques that enhance the early detection and personalized treatment of gastrointestinal cancers.

šŸ‘©ā€šŸ« Contributions to Medical Science & Education

Beyond her research, Dr. Chong Wei is committed to mentoring young scientists and medical professionals. As a Postdoctoral Supervisor and Master’s Advisor, she guides researchers in oncology and gastrointestinal studies, fostering innovation in clinical and laboratory research.

Noted PublicationsšŸ“

Article: Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer
  • Authors: Ge Cong, Xingyu Zhu, Xin Ru Chen, Hao Chen, Wei Chong
    Journal: Cell Death Discovery
    Year: 2025
Article: Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer
  • Authors: Chen H, Jing C, Shang L, Zhu X, Zhang R, Liu Y, Wang M, Xu K, Ma T, Jing H et al.
    Journal: Cell Reports
    Year: 2024
Article: Clinical features and molecular landscape of cuproptosis signature‐related molecular subtype in gastric cancer
  • Authors: Wei Chong, Huicheng Ren, Hao Chen, Kang Xu, Xingyu Zhu, Yuan Liu, Yaodong Sang, Han Li, Jin Liu, Chunshui Ye et al.
    Journal: iMeta
    Year: 2024
Article: Research progress of exosomes in the angiogenesis of digestive system tumour
  • Authors: Yuan Liu, Hao Wu, Yaodong Sang, Wei Chong, Liang Shang, Leping Li
    Journal: Discover Oncology
    Year: 2024
Article: Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses insulin-like growth factor 1 receptor expression to inhibit cell adhesion and proliferation in gastric cancer
  • Authors: Zhang Z, Wang X, Liu Y, Wu H, Zhu X, Ye C, Ren H, Chong W, Shang L, Li L
    Journal: MedComm
    Year: 2024